Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

411 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Gemcitabine and anthracyclines in breast cancer.
Jassem J. Jassem J. Semin Oncol. 2003 Apr;30(2 Suppl 3):11-4. doi: 10.1053/sonc.2003.37269. Semin Oncol. 2003. PMID: 12722019 Review.
Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab.
Duchnowska R, Sperinde J, Czartoryska-Arłukowicz B, Myśliwiec P, Winslow J, Radecka B, Petropoulos C, Demlova R, Orlikowska M, Kowalczyk A, Lang I, Ziółkowska B, Dębska-Szmich S, Merdalska M, Grela-Wojewoda A, Żawrocki A, Biernat W, Huang W, Jassem J. Duchnowska R, et al. Among authors: jassem j. Oncotarget. 2017 Oct 24;8(61):104149-104159. doi: 10.18632/oncotarget.22027. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262628 Free PMC article.
Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer.
Müller V, Clemens M, Jassem J, Al-Sakaff N, Auclair P, Nüesch E, Holloway D, Shing M, Bang YJ. Müller V, et al. Among authors: jassem j. BMC Cancer. 2018 Mar 15;18(1):295. doi: 10.1186/s12885-018-4183-2. BMC Cancer. 2018. PMID: 29544445 Free PMC article.
Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation.
Hryciuk B, Szymanowski B, Romanowska A, Salt E, Wasąg B, Grala B, Jassem J, Duchnowska R. Hryciuk B, et al. Among authors: jassem j. Oncol Lett. 2018 Feb;15(2):1912-1916. doi: 10.3892/ol.2017.7473. Epub 2017 Nov 22. Oncol Lett. 2018. PMID: 29434889 Free PMC article.
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.
Clarke N, Wiechno P, Alekseev B, Sala N, Jones R, Kocak I, Chiuri VE, Jassem J, Fléchon A, Redfern C, Goessl C, Burgents J, Kozarski R, Hodgson D, Learoyd M, Saad F. Clarke N, et al. Among authors: jassem j. Lancet Oncol. 2018 Jul;19(7):975-986. doi: 10.1016/S1470-2045(18)30365-6. Epub 2018 Jun 4. Lancet Oncol. 2018. PMID: 29880291 Clinical Trial.
Highlights from the San Antonio Breast Cancer Symposium 2015.
Jassem J. Jassem J. ESMO Open. 2016 Feb 26;1(1):e000043. doi: 10.1136/esmoopen-2016-000043. eCollection 2016. ESMO Open. 2016. PMID: 27843589 Free PMC article.
Pulsed-dose-rate peri-operative brachytherapy as an interstitial boost in organ-sparing treatment of breast cancer.
Serkies K, Jaśkiewicz J, Dziadziuszko R, Jassem J. Serkies K, et al. Among authors: jassem j. J Contemp Brachytherapy. 2016 Dec;8(6):492-496. doi: 10.5114/jcb.2016.64512. Epub 2016 Dec 9. J Contemp Brachytherapy. 2016. PMID: 28115954 Free PMC article.
Delays in diagnosis and treatment of breast cancer: a multinational analysis.
Jassem J, Ozmen V, Bacanu F, Drobniene M, Eglitis J, Lakshmaiah KC, Kahan Z, Mardiak J, Pieńkowski T, Semiglazova T, Stamatovic L, Timcheva C, Vasovic S, Vrbanec D, Zaborek P. Jassem J, et al. Eur J Public Health. 2014 Oct;24(5):761-7. doi: 10.1093/eurpub/ckt131. Epub 2013 Sep 12. Eur J Public Health. 2014. PMID: 24029456
Partial breast irradiation techniques in early breast cancer.
Kacprowska A, Jassem J. Kacprowska A, et al. Among authors: jassem j. Rep Pract Oncol Radiother. 2011 Oct 14;16(6):213-20. doi: 10.1016/j.rpor.2011.08.003. Rep Pract Oncol Radiother. 2011. PMID: 24376983 Free PMC article. Review.
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.
Ruhstaller T, Giobbie-Hurder A, Colleoni M, Jensen MB, Ejlertsen B, de Azambuja E, Neven P, Láng I, Jakobsen EH, Gladieff L, Bonnefoi H, Harvey VJ, Spazzapan S, Tondini C, Del Mastro L, Veyret C, Simoncini E, Gianni L, Rochlitz C, Kralidis E, Zaman K, Jassem J, Piccart-Gebhart M, Di Leo A, Gelber RD, Coates AS, Goldhirsch A, Thürlimann B, Regan MM; members of the BIG 1-98 Collaborative Group and the International Breast Cancer Study Group. Ruhstaller T, et al. Among authors: jassem j. J Clin Oncol. 2019 Jan 10;37(2):105-114. doi: 10.1200/JCO.18.00440. Epub 2018 Nov 26. J Clin Oncol. 2019. PMID: 30475668 Free PMC article. Clinical Trial.
411 results
Jump to page
Feedback